Preliminary report of a new type of braided vein stent in animals

Abstract

Background

Iliofemoral vein stenosis or occlusion is a common cause of severe chronic venous insufficiency. Endovascular venous stenting has become a preferred treatment because it is minimally invasive and has a high safety profile. Despite the wide application of the wallstent, it is not specifically designed for veins. There are currently few studies on braided stents in the field of veins. We designed a novel braided vein stent, which has higher radial resistive force and more optimized looped ends structure compared with the wallstent. The purpose of this study was to evaluate the safety and performance of the stent in animals, providing a reference for further clinical trials.

Methods

The Wallstent is used as a control group. The novel stent and the Wallstent were implanted in the iliac vein of sheep. After 30 days and 90 days, vascular injury, thrombus, neointima coverage, and luminal stenosis were evaluated through venous angiography, endoscopic observation of stent specimen and histopathology. Imaging, histology, and integration data were analyzed by t-test for comparisons between the groups.

Results

Two groups of stents were successfully implanted. Follow-up observation showed that there was no thrombosis or obstruction >50% occurred in any group and no significant differences in patency, vascular injury, or intimal hyperplasia compared with the Wallstent.

Conclusion

The novel stent significantly increases the radial resistive force and does not increase vascular injury, thrombus and stent stenosis during 30-day and 90-day follow-up. The next step is to further validate the effectiveness of the stent through long-term animal observation and human clinical trials.

Keywords

Chronic venous insufficiency deep venous insufficiency endovascular treatment May–Thurner syndrome stents

Get full access to this article

View all access options for this article.

References

May

Thurner

The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins.

Angiology 1957; 8: 419–427.

Kibbe

Ujiki

Goodwin

et al . Iliac vein compression in an asymptomatic patient population. J Vasc Surg 2004; 39: 937–943.

Semba

Dake

MD.

Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis.

Radiology 1994; 191: 487–494.

Raju

Treatment of iliac-caval outflow obstruction.

Semin Vasc Surg 2015; 28: 47–53.

Hartung

Loundou

Barthelemy

et al . Endovascular management of chronic disabling iliocaval obstructive lesions: long-term results. Eur J Vasc Endovasc Surg 2009; 38: 118–124.

Razavi

Jaff

Miller

LE.

Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systemtic review and meta-analysis.

Circ Cardiovasc Interv 2015: 8: 10.

Mahnken

Thomson

de Haan

et al.

CIRSE standards of practice guidelines on iliocaval stenting. Cardiovasc Intervent Radiol 2014; 37: 889–897.

O’Donnell

Jr Passman

Marston

et al . Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2014; 60: 3S–59S.

William

Marston

Abha Chinubhai

et al.

In vivo evaluation of safety and performance of a nitinol venous stent in an ovine iliac venous model.

J Vasc Surg Venous Lymphat Disord 2016; 4: 73–79.

10.

Dabir

Feisst

Thomas

et al . Physical properties of venous stents: an experimental comparison. Cardiovasc Intervent Radiol 2018; 41: 942–950.

11.

Raju

Best management options for chronic iliac vein stenosis and occlusion.

J Vasc Surg 2013; 57: 1163–1169.

12.

et al . Long-term outcomes of stent placement for symptomatic nonthrombotic iliac vein compression lesions in chronic venous disease. J Vasc Interv Radiol 2012; 23: 497–502.

13.

Titus

Moise

Bena

et al . Iliofemoral stenting for venous occlusive disease. J Vasc Surg 2011; 53: 706–712.

14.

Haurtung

Benmiloud

Barthelemy

et al . Late results of surgical venous thrombectomy with iliocaval stenting. J Vasc Surg 2008; 47: 381–387.

15.

Nazir

Ganeshan

Nazir

et al . Endovascular treatment options in the management of lower limb deep venous thrombosis. CardiovascIntervention Radiol 2009; 32: 861–876.

16.

Neglen

Hollis

Olivier

et al . Stenting of the venous outflow in chronic venous disease: long-term stem-related outcome, clinical, and hemodynamic result. J Vasc Surg 2007; 46: 979–990.

17.

O’Sullivan

. Endovascular management of chronic iliac venous occlusion.

Tech Vasc Interv Radiol 2000; 3: 45–53.

18.

Gasparis

Labropoulos

Venous outflow obstruction managing intervention after iliofemoral thrombolysis. Endovasc Today 2011; 2: 51–56.

19.

de Wolf

de Graaf

Kurstjens

et al . Short-term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent. Eur J Vasc Endovasc Surg 2015; 50: 518–526.

20.

Asri

RIM

Harun

WSW

Samykano

et al . Corrosion and surface modification on biocompatible metals: a review. Mater Sci Eng C Mater Biol Appl 2017; 77: 1261–1274.

21.

Hanawa

In vivo metallic biomaterials and surface modification.

Mater Sci Eng A 1999; 267: 260–266.

22.

Gotman

Characteristics of metals used in implants.

J Endourol 1997; 11: 383–389.

23.

Shanahan

Tiernan

Tofail

SAM.

Looped ends versus open ends braided stent: a comparison of the mechanical behavior using analytical and numerical methods.

J Mech Behav Biomed Mater 2017; 75: 581–591.

24.

Garasic

Edelman

Squire

et al . Stent and artery geometry determine intimal thickening independent of arterial injury. Circulation 2000; 101: 812–818.

25.

Knuttinen

Naidu

Oklu

et al . May-Thurner: diagnosis and endovascular management. Cardiovasc Diagn Ther 2017; 7: S159–S164.

26.

Zhang

Chen

Sun

et al . Influence of iliac vein stent implantation on the contralateral iliac vein. Vasc Endovascular Surg 2015; 49: 119–123.